doi: 10.1128/JVI.65.5.2718-2723.1991.
Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates
Affiliations
- PMID: 1707985
- PMCID: PMC240636
- DOI: 10.1128/JVI.65.5.2718-2723.1991
Item in Clipboard
Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates
J Virol.
1991 May.
Abstract
Immunoreactive regions of human immunodeficiency virus type 1 (HIV-1) gp41 were mapped by reacting HIV-1 antibody-positive human sera with overlapping synthetic peptides which covered the transmembrane protein. Three immunoreactive domains were identified, and five different and partially overlapping epitopes recognized by HIV-1-positive human sera were found within one immunodominant region. The effect on antibody recognition after single amino acid substitutions within one defined epitope was also studied. The reactivity of various HIV-1-positive sera to synthetic peptides with amino acid substitutions representing known isolates suggests an important substitution in the major epitope of African HIV-1 strains.
Similar articles
-
Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.Virology. 2000 Apr 25;270(1):135-45. doi: 10.1006/viro.2000.0269. Virology. 2000. PMID: 10772986
-
A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.AIDS. 1993 Jun;7(6):759-67. doi: 10.1097/00002030-199306000-00002. AIDS. 1993. PMID: 8363754
-
Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.AIDS Res Hum Retroviruses. 1996 May 20;12(8):705-13. doi: 10.1089/aid.1996.12.705. AIDS Res Hum Retroviruses. 1996. PMID: 8744581
-
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):461-5. doi: 10.1073/pnas.89.2.461. Proc Natl Acad Sci U S A. 1992. PMID: 1370580 Free PMC article.
-
[Peptides from the principal neutralizing and CD4-binding domain: similar immunoreactive properties and structure pattern].Vestn Ross Akad Med Nauk. 1992;(9-10):47-52. Vestn Ross Akad Med Nauk. 1992. PMID: 1283721 Review. Russian.
Cited by
-
Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity.Retrovirology. 2007 Sep 28;4:69. doi: 10.1186/1742-4690-4-69. Retrovirology. 2007. PMID: 17903253 Free PMC article.
-
Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.J Virol. 2002 Dec;76(23):12123-34. doi: 10.1128/jvi.76.23.12123-12134.2002. J Virol. 2002. PMID: 12414953 Free PMC article.
-
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.Microbiol Mol Biol Rev. 2008 Mar;72(1):54-84, table of contents. doi: 10.1128/MMBR.00020-07. Microbiol Mol Biol Rev. 2008. PMID: 18322034 Free PMC article. Review.
-
B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins.J Virol. 1993 Feb;67(2):664-72. doi: 10.1128/JVI.67.2.664-672.1993. J Virol. 1993. PMID: 7678301 Free PMC article.
-
Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10744-8. doi: 10.1073/pnas.88.23.10744. Proc Natl Acad Sci U S A. 1991. PMID: 1961741 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
